The pharmaceutical industry is currently witnessing a significant gathering of expertise and leadership at an offline The IV Eurasian Pharmaceutical Summit continues in Samarkand, with over 250 prominent experts and regulators hailing from 10 different countries actively participating. Additionally, this summit boasts the engagement of over 100 speakers representing pharmaceutical manufacturing firms, distributors, and pharmacy networks.
The event features the presence of top officials and managers from various system organizations, all operating under the guidance of the director of the Pharmaceutical Network Development Agency.
The comprehensive summit program encompasses a rich array of over 20 sessions. These sessions serve as forums for in-depth discussions on a wide spectrum of pharmaceutical topics, including regulatory policy, public procurement, labeling, pricing, sales, marketing, and drug manufacturing. Beyond the sessions, the summit also facilitates roundtable discussions and one-on-one meetings, affording participants the invaluable opportunity to interact directly with top executives of leading pharmaceutical companies. Regulatory bodies actively participate in these discussions, further enhancing the depth and breadth of insights shared during the event.
Earlier Daryo reported that the 26th session of the Intergovernmental Council for Subsoil Activities in CIS Countries took place in Samarkand on September 21-22, 2023, with active involvement from delegations representing Kazakhstan, Kyrgyzstan, Tajikistan, Russia, and Belarus.